Research progress of implantation materials and its biological evaluation

With the development of modern material science, life science and medical science, implantation materials are widely employed in clinical fields. In recent years, these materials have also evolved from inert supports or functional substitutes to bioactive materials able to trigger or promote the regenerative potential of tissues. Reasonable biological evaluation of implantation materials is the premise to make sure their safe application in clinical practice. With the continual development of implantation materials and the emergence of new implantation materials, new challenges to biological evaluation have been presented. In this paper, the research progress of implantation materials, the progress of biological evaluation methods, and also the characteristics of biocompatibility evaluation for novel implantation materials, like animal-derived implantation materials, nerve contact implantation materials, nanomaterials and tissue-engineered medical products were reviewed in order to provide references for the rational biological evaluation of implantable materials.

[1]  David F. Williams The plasticity of biocompatibility. , 2023, Biomaterials.

[2]  M. A. Mirza,et al.  Raw Materials, Technology, Healthcare Applications, Patent Repository and Clinical Trials on 4D Printing Technology: An Updated Review , 2022, Pharmaceutics.

[3]  Jiandong Ding,et al.  Recent advances in regenerative biomaterials , 2022, Regenerative biomaterials.

[4]  A. Khademhosseini,et al.  Recent advances in biopolymer-based hemostatic materials , 2022, Regenerative biomaterials.

[5]  Vinicius M. Alves,et al.  PreS/MD: Predictor of Sensitization hazard for chemical substances released from Medical Devices. , 2022, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Robin Kumoluyi,et al.  Risk Management in Drug-Device Combination Product Development , 2022, Therapeutic Innovation & Regulatory Science.

[7]  Zixun Wang,et al.  Establishing a novel 3D printing bioinks system with recombinant human collagen. , 2022, International journal of biological macromolecules.

[8]  Sidra Ajmal,et al.  Recent progress in development and applications of biomaterials , 2022, Materials Today: Proceedings.

[9]  Jingming Gao,et al.  Biomaterial-related cell microenvironment in tissue engineering and regenerative medicine , 2022, Engineering.

[10]  J. A. Sánchez-Margallo,et al.  Systematic Review of Tissue-Engineered Vascular Grafts , 2021, Frontiers in Bioengineering and Biotechnology.

[11]  L. Teuschler,et al.  Exploring the utility of the Threshold of Toxicological Concern (TTC) as a screening approach for complex substances. , 2021, Regulatory toxicology and pharmacology : RTP.

[12]  Ariel A. Szklanny,et al.  3D Bioprinting of Engineered Tissue Flaps with Hierarchical Vessel Networks (VesselNet) for Direct Host‐To‐Implant Perfusion , 2021, Advanced materials.

[13]  Wei Xu,et al.  Regulatory perspectives of combination products , 2021, Bioactive materials.

[14]  Antonios G. Mikos,et al.  Machine learning and medical devices: The next step for tissue engineering , 2021, Engineering.

[15]  Julie Lien Paternoster,et al.  State of the art of clinical applications of Tissue Engineering in 2021. , 2021, Tissue engineering. Part B, Reviews.

[16]  M. Longaker,et al.  Mechanisms of bone development and repair , 2020, Nature Reviews Molecular Cell Biology.

[17]  J. Pérez-Villares,et al.  Promoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine , 2020, Cytotherapy.

[18]  Meiyu Wu,et al.  In vivo carcinogenicity study of silver nanoparticles in transgenic rasH2 mice by one single-dose intravenous administration , 2020, Journal of Nanoparticle Research.

[19]  Sydney D Menikheim,et al.  Self-healing biomaterials: The next generation is nano. , 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[20]  C. Rudge,et al.  Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics. , 2020, Regenerative medicine.

[21]  S. Gad Integrated Safety and Risk Assessment for Medical Devices and Combination Products , 2020 .

[22]  Viviana Siddhi Self-Healing , 2020, Online Journal of Complementary & Alternative Medicine.

[23]  L. Ye,et al.  Preparation and in vivo evaluation of surface heparinized small diameter tissue engineered vascular scaffolds of poly(ε-caprolactone) embedded with collagen suture , 2020, Journal of biomaterials applications.

[24]  M. Akrami,et al.  Recent progress in biomedical applications of RGD-Based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review. , 2019, Journal of biomedical materials research. Part A.

[25]  W. Jia,et al.  Hyaluronic acid oligosaccharide-modified collagen nanofibers as vascular tissue-engineered scaffold for promoting endothelial cell proliferation. , 2019, Carbohydrate polymers.

[26]  J. Ge,et al.  Twelve-month angiographic and clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold and a metallic stent in patients with coronary artery disease. , 2019, International journal of cardiology.

[27]  Gopal Pawar,et al.  In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR , 2019, Front. Pharmacol..

[28]  Gi Hoon Yang,et al.  4D Bioprinting: Technological Advances in Biofabrication. , 2019, Macromolecular bioscience.

[29]  D. Tousoulis,et al.  3D Bioprinting Methods and Techniques: Applications on Artificial Blood Vessel Fabrication. , 2019, Acta Cardiologica Sinica.

[30]  D. Pezzoli,et al.  Heparin-Modified Collagen Gels for Controlled Release of Pleiotrophin: Potential for Vascular Applications , 2019, Front. Bioeng. Biotechnol..

[31]  Liming Xu,et al.  Xenogeneic bone matrix immune risk assessment using GGTA1 knockout mice , 2018, Artificial cells, nanomedicine, and biotechnology.

[32]  Changyong Liu,et al.  A Novel Strategy for Creating Tissue-Engineered Biomimetic Blood Vessels Using 3D Bioprinting Technology , 2018, Materials.

[33]  Feng Zhao,et al.  Tissue Engineering at the Blood‐Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development , 2018, Advanced healthcare materials.

[34]  Tina Krenc,et al.  Exploring Potential Revisions to ISO 14971 and ISO/TR 24971. , 2018, Biomedical instrumentation & technology.

[35]  Takashi D Y Kozai,et al.  Understanding the Inflammatory Tissue Reaction to Brain Implants To Improve Neurochemical Sensing Performance. , 2017, ACS chemical neuroscience.

[36]  Chuanglong He,et al.  Local Delivery of BMP-2 from Poly(lactic-co-glycolic acid) Microspheres Incorporated into Porous Nanofibrous Scaffold for Bone Tissue Regeneration. , 2017, Journal of biomedical nanotechnology.

[37]  M. Khattab,et al.  Novel approach to gastric mucosal defect repair using fresh amniotic membrane allograft in dogs (experimental study) , 2017, Stem Cell Research & Therapy.

[38]  Yujiang Fan,et al.  In vivo immunological properties research on mesenchymal stem cells based engineering cartilage by a dialyzer pocket model , 2017, Journal of Materials Science: Materials in Medicine.

[39]  Zimeng Zhang,et al.  3D bioprinting of soft materials-based regenerative vascular structures and tissues , 2017 .

[40]  Nikolaj Gadegaard,et al.  Nacre Topography Produces Higher Crystallinity in Bone than Chemically Induced Osteogenesis. , 2017, ACS nano.

[41]  H. Sakaguchi,et al.  An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens. , 2017, Toxicology in vitro : an international journal published in association with BIBRA.

[42]  Jenna L. Dziki,et al.  Macrophage phenotype in response to ECM bioscaffolds. , 2017, Seminars in immunology.

[43]  D. Gauvin,et al.  The standardized functional observational battery: Its intrinsic value remains in the instrument of measure: The rat. , 2016, Journal of pharmacological and toxicological methods.

[44]  B. Thomas,et al.  Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice , 2016, Neuropharmacology.

[45]  Sebastian Hoffmann,et al.  Intra- and inter-laboratory reproducibility and accuracy of the LuSens assay: A reporter gene-cell line to detect keratinocyte activation by skin sensitizers. , 2016, Toxicology in vitro : an international journal published in association with BIBRA.

[46]  T. Wynn,et al.  Macrophages in Tissue Repair, Regeneration, and Fibrosis. , 2016, Immunity.

[47]  Jingtian Hu,et al.  Predicting carcinogenicity of organic compounds based on CPDB. , 2015, Chemosphere.

[48]  Michael Glogauer,et al.  Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials , 2015, Materials.

[49]  L. Unsworth,et al.  Engineering 3D Cellularized Collagen Gels for Vascular Tissue Regeneration , 2015, Journal of visualized experiments : JoVE.

[50]  Claude Auriault,et al.  Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[51]  A. Baker,et al.  Nanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia. , 2015, ACS nano.

[52]  Benjamin M Wu,et al.  Recent advances in 3D printing of biomaterials , 2015, Journal of Biological Engineering.

[53]  J. Teixeira,et al.  Effects of iron oxide nanoparticles: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity , 2015, Environmental and molecular mutagenesis.

[54]  Robert Landsiedel,et al.  LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.

[55]  Chengtie Wu,et al.  Crosslinking of saphenous vein ECM by procyanidins for small diameter blood vessel replacement. , 2014, Journal of biomedical materials research. Part B, Applied biomaterials.

[56]  P. Bruegger,et al.  Cryopreservation of human monocytes for pharmacopeial monocyte activation test. , 2014, Journal of immunological methods.

[57]  Yujiang Fan,et al.  Collagen hydrogel as an immunomodulatory scaffold in cartilage tissue engineering. , 2014, Journal of biomedical materials research. Part B, Applied biomaterials.

[58]  Elliot L Chaikof,et al.  Acellular vascular grafts generated from collagen and elastin analogs. , 2013, Acta biomaterialia.

[59]  Gary L Bowlin,et al.  Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds. , 2013, Biomaterials.

[60]  M. Wenk,et al.  Historical Control Data of Spontaneous Tumors in Transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) Mice , 2013, International journal of toxicology.

[61]  C. V. van Blitterswijk,et al.  Bioinformatics-based selection of a model cell type for in vitro biomaterial testing. , 2012, Biomaterials.

[62]  Yuji Naito,et al.  Development of tissue engineered vascular grafts and application of nanomedicine. , 2012, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[63]  Sumit Arora,et al.  Nanotoxicology and in vitro studies: the need of the hour. , 2012, Toxicology and applied pharmacology.

[64]  W. D. de Jong,et al.  The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. , 2011, Biomaterials.

[65]  A. Piersma,et al.  Comparison of the mouse Embryonic Stem cell Test, the rat Whole Embryo Culture and the Zebrafish Embryotoxicity Test as alternative methods for developmental toxicity testing of six 1,2,4-triazoles. , 2011, Toxicology and applied pharmacology.

[66]  R Damoiseaux,et al.  No time to lose--high throughput screening to assess nanomaterial safety. , 2011, Nanoscale.

[67]  G. Gerosa,et al.  First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. , 2011, Acta biomaterialia.

[68]  William M Reichert,et al.  Self-healing biomaterials. , 2011, Journal of biomedical materials research. Part A.

[69]  G. Long,et al.  Alternative Mouse Models for Carcinogenicity Assessment: Industry Use and Issues with Pathology Interpretation , 2010, Toxicologic pathology.

[70]  Samir Mitragotri,et al.  Designer Biomaterials for Nanomedicine , 2009 .

[71]  Sing Yian Chew,et al.  The application of nanofibrous scaffolds in neural tissue engineering. , 2009, Advanced drug delivery reviews.

[72]  David F. Williams On the nature of biomaterials. , 2009, Biomaterials.

[73]  David F. Williams,et al.  Different directions for the biological evaluation of biomaterials. , 2009, Medical device technology.

[74]  X. Palazzi,et al.  Use of rasH2 transgenic mice for carcinogenesis testing of medical implants. , 2009, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[75]  R. Hamel,et al.  Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: Need for multiparametric evaluation due to adsorption artifacts , 2009, Inhalation toxicology.

[76]  N. Monteiro-Riviere,et al.  Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. , 2009, Toxicology and applied pharmacology.

[77]  David F. Williams On the mechanisms of biocompatibility. , 2008, Biomaterials.

[78]  T. Bertram,et al.  Tissue Engineering and Regenerative Medicine: Role of Toxicologic Pathologists for an Emerging Medical Technology , 2008, Toxicologic pathology.

[79]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[80]  P. Tresco,et al.  Response of brain tissue to chronically implanted neural electrodes , 2005, Journal of Neuroscience Methods.

[81]  Liping Tang,et al.  Molecular determinants of biocompatibility , 2005, Expert review of medical devices.

[82]  J. O'Callaghan,et al.  Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity , 2005, Expert opinion on drug safety.

[83]  Sebastian Hoffmann,et al.  International validation of novel pyrogen tests based on human monocytoid cells. , 2005, Journal of immunological methods.

[84]  L. Schmued,et al.  Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons , 2005, Brain Research.

[85]  Aldert H Piersma,et al.  Validation of the Rat Limb Bud Micromass Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[86]  Aldert Piersma,et al.  The ECVAM International Validation Study on In Vitro Embryotoxicity Tests: Results of the Definitive Phase and Evaluation of Prediction Models , 2002, Alternatives to laboratory animals : ATLA.

[87]  E Regar,et al.  Stent development and local drug delivery. , 2001, British medical bulletin.

[88]  M. Akashi,et al.  Evaluation of biological responses to polymeric biomaterials by RT-PCR analysis IV: study of c-myc, c-fos and p53 mRNA expression. , 2000, Biomaterials.

[89]  H. Tilson,et al.  In vitro techniques for the assessment of neurotoxicity. , 1998, Environmental health perspectives.

[90]  K. Lampe,et al.  Biomaterials via Peptide Assembly: Design, Characterization, and Application in Tissue Engineering , 2021, Acta biomaterialia.

[91]  Kandice M. Nappier,et al.  Toxicity of Common Extractables and Leachables of Medical Devices , 2019, Integrated Safety and Risk Assessment for Medical Devices and Combination Products.

[92]  Thomas Hartung,et al.  From in vivo to in vitro: The medical device testing paradigm shift. , 2017, ALTEX.

[93]  S. Walsh,et al.  Comparing the endothelialisation of extracellular matrix bioscaffolds with coated synthetic vascular graft materials. , 2016, International journal of surgery.

[94]  F. Clauss,et al.  Nanostructured thick 3D nanofibrous scaffold can induce bone. , 2015, Bio-medical materials and engineering.

[95]  C. Schneider,et al.  The evolution of nonclinical regulatory science: advanced therapy medicinal products as a paradigm. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[96]  S. Doak,et al.  NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. , 2009, Biomaterials.

[97]  D. Farmer,et al.  Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX). , 2000, Teratogenesis, carcinogenesis, and mutagenesis.

[98]  M S Chapekar,et al.  Tissue engineering: challenges and opportunities. , 2000, Journal of biomedical materials research.